Vimal Mehta, CEO, President, Secretary at BioXcel Therapeutics, Inc. (BTAI), bought 1,000 shares at $5.15 ($5K) on 2018-12-04, disclosed to the SEC on 2018-12-04.
Open-market purchase of $5k BTAI by CEO, President, Secretary. Below the thresholds we flag for high-conviction alerts (no C-suite role, rare reversal, cluster, or A-grade history).
Something here stands out, but not much.
| # | Price | Shares | Value | % of Total |
|---|---|---|---|---|
| 1 | $5.09 | 500 | $3K | 49.7% |
| 2 | $5.15 | 500 | $3K | 50.3% |
| Total | $5.12 avg | 1,000 | $5K | 100% |
| Filing → |
| BTAI | SELL | 2024-09-17 | $1K | — | Filing → |
| BTAI | SELL | 2024-06-18 | $3K | — | Filing → |
| BTAI | SELL | 2024-04-08 | $14K | — | Filing → |